𝐖𝐡𝐲 𝐢𝐬 𝐁𝐢𝐨𝐛𝐮𝐫𝐝𝐞𝐧 𝐓𝐞𝐬𝐭𝐢𝐧𝐠 𝐩𝐞𝐫𝐟𝐨𝐫𝐦𝐞𝐝 𝐛𝐞𝐟𝐨𝐫𝐞 𝐬𝐭𝐞𝐫𝐢𝐥𝐢𝐳𝐚𝐭𝐢𝐨𝐧?

Bioburden testing is performed before sterilization to measure the number and types of viable microorganisms contaminating a product.
It serves as a vital preventive tool to validate the sterilization process, ensure patient safety, and maintain compliance with manufacturing regulations.

𝐖𝐡𝐲 𝐈𝐬 𝐁𝐢𝐨𝐛𝐮𝐫𝐝𝐞𝐧 𝐓𝐞𝐬𝐭𝐢𝐧𝐠 𝐈𝐦𝐩𝐨𝐫𝐭𝐚𝐧𝐭?
Bioburden testing provides a measure of the contaminants present on a medical device or piece of equipment, just prior to the final sterilization process before implantation or patient interaction.
An accurate bioburden measurement allows for proper selection of sterilization process, as well as calibration and measurement of the level of sterilization required.

Bioburden also acts as an indicator of the level of control over contaminants in the manufacturing process.
Without a bioburden analyser, it is possible that improper or incorrect sterilization methods may be used, or that sterilization may not be executed thoroughly enough which may result in the presence of unwanted microbes when the device is implanted or used.

The vital step in bioburden testing is the collection of samples or recovery methods of microorganisms from products and medical devices. Bioburden testing is highly used in pharmaceutical industries, manufacturers of medical devices, and cosmetics industries.

Procedure of Bioburden Testing

• 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐫𝐞𝐩𝐚𝐫𝐚𝐭𝐢𝐨𝐧 & 𝐄𝐱𝐭𝐫𝐚𝐜𝐭𝐢𝐨𝐧
  Microorganisms are removed from the product using suitable techniques such as rinsing, swabbing, sonication, or direct immersion, depending on the product type.
• 𝐌𝐢𝐜𝐫𝐨𝐨𝐫𝐠𝐚𝐧𝐢𝐬𝐦 𝐈𝐬𝐨𝐥𝐚𝐭𝐢𝐨𝐧
  The extracted sample is filtered, usually through a 0.45 µm membrane filter, to capture microorganisms and remove any interfering substances.
• 𝐂𝐮𝐥𝐭𝐮𝐫𝐢𝐧𝐠 & 𝐈𝐧𝐜𝐮𝐛𝐚𝐭𝐢𝐨𝐧
  The membrane or sample is transferred to appropriate culture media and incubated under specified conditions to allow microorganisms to grow.
• 𝐄𝐧𝐮𝐦𝐞𝐫𝐚𝐭𝐢𝐨𝐧
  After incubation, the colonies are counted and reported as Colony Forming Units (CFU). The results are expressed as Total Aerobic Microbial Count (TAMC) and Total Yeast and Mold Count (TYMC).
• 𝐑𝐞𝐬𝐮𝐥𝐭 𝐄𝐯𝐚𝐥𝐮𝐚𝐭𝐢𝐨𝐧 & 𝐑𝐞𝐩𝐨𝐫𝐭𝐢𝐧𝐠
  The microbial count is compared with predefined acceptance criteria. The final results help assess process hygiene and determine whether the product is suitable for sterilization.

1.  

𝐖𝐡𝐲 𝐈𝐬 𝐁𝐢𝐨𝐛𝐮𝐫𝐝𝐞𝐧 𝐀𝐬𝐬𝐞𝐬𝐬𝐦𝐞𝐧𝐭 𝐈𝐦𝐩𝐨𝐫𝐭𝐚𝐧𝐭?
A well-designed bioburden assessment helps pharmaceutical manufacturers:

• Evaluate the effectiveness of cleaning and sanitation
• Monitor the microbiological quality of the manufacturing process
• Support sterilization validation
• Detect contamination trends early
• Ensure GMP compliance
• Protect product quality and patient safety